ENTHEON BIOMEDICAL CORP To Carry Out 1-for-10 Reverse Stock Split On March 1st, 2024

Moomoo NewsFeb 28 19:40 ET

RBC Downgrades Nevro to Sector Perform, Cites Salesforce Turnaround

Seeking AlphaJan 12 11:01 ET

Psyched: Elon Musk Tweets About Psychedelics, Numinus Acquires Novamind, Colorado Gov. Signs MDMA Legalization Bill

Benzinga Real-time NewsJun 15, 2022 12:34 ET

Largest Phase-1 DMT Study In The Netherlands, A Collaboration Between Entheon & Cybin

Benzinga Real-time NewsJun 7, 2022 17:10 ET

Cybin to acquire DMT clinical study from Entheon Biomedical

Seeking AlphaJun 7, 2022 08:28 ET

Ehave Partners With Halugen Life Sciences To Create A Ketamine Precision Medicine Platform For Clinical Research

Benzinga Real-time NewsJun 1, 2022 16:30 ET